Back to Search
WOLFRAM SAMLOWSKI, MD
MD
Hematology & Oncology Physician
NPI: 1396810834IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
166160-1205(UT)12318(NV)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1978
Research & Publications (20)
Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
PMID 18780316·Cancer·2008
8-other
Management of renal cancer in the tyrosine kinase inhibitor era: a view from 3 years on.
PMID 18410430·BJU Int·2008
6-review
Emerging drugs for the treatment of metastatic renal cancer.
PMID 17979602·Expert Opin Emerg Drugs·2007
6-review
Multimodality management of brain metastases in metastatic melanoma patients.
PMID 18062744·Expert Rev Anticancer Ther·2007
6-review
Long-term response in primary renal cancer to sequential antiangiogenic therapy.
PMID 19667262·J Clin Oncol·2009
5-case
Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brain.
PMID 19665029·J Immunol Methods·2009
7-preclinical
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008.
PMID 19659612·Pigment Cell Melanoma Res·2009
8-other
Image of the month. Hemoptysis in a patient with melanoma and pulmonary infiltrates.
PMID 19057274·J Thorac Oncol·2008
5-case
Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery.
PMID 19248682·Clin Neurosurg·2008
8-other
Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
PMID 18391763·J Immunother·2008
7-preclinical
Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
PMID 18337833·J Invest Dermatol·2008
8-other
N-acetylcysteine protects melanocytes against oxidative stress/damage and delays onset of ultraviolet-induced melanoma in mice.
PMID 17908992·Clin Cancer Res·2007
7-preclinical
Management of metastatic melanoma patients with brain metastases.
PMID 17706170·Curr Oncol Rep·2007
6-review
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases.
PMID 17623835·Cancer·2007
8-other
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
PMID 17513813·J Clin Oncol·2007
4-observational
Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
PMID 17351953·Cancer·2007
8-other
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
PMID 17264760·Anticancer Drugs·2007
3-trial
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
PMID 16779801·Cancer·2006
3-trial
Kidney cancer. Clinical practice guidelines in oncology.
PMID 17112454·J Natl Compr Canc Netw·2006
6-review
Testicular cancer. Clinical practice guidelines in oncology.
PMID 17112452·J Natl Compr Canc Netw·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 9139 W Russell Rd Ste 200
Las Vegas, NV 89148 - Phone
- (702) 473-1757
Quick Facts
- NPI
- 1396810834
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 48
- Publications
- 20
Are you this provider?
Claim Your Profile